| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 257.66M | 312.47M | 401.98M | 514.80M | 469.62M | 366.62M |
| Gross Profit | 162.93M | 192.81M | 231.17M | 303.90M | 293.46M | 245.97M |
| EBITDA | -32.06M | -70.74M | -36.64M | -164.12M | -53.12M | -64.12M |
| Net Income | -133.26M | -134.27M | -100.44M | -225.75M | -124.97M | -107.59M |
Balance Sheet | ||||||
| Total Assets | 511.45M | 607.78M | 835.51M | 1.09B | 1.19B | 1.01B |
| Cash, Cash Equivalents and Short-Term Investments | 106.66M | 183.24M | 212.93M | 391.78M | 521.85M | 654.15M |
| Total Debt | 382.41M | 527.23M | 591.89M | 742.83M | 584.09M | 551.33M |
| Total Liabilities | 512.84M | 675.09M | 787.38M | 1.02B | 837.22M | 762.50M |
| Stockholders Equity | -1.39M | -67.32M | 48.14M | 68.09M | 349.44M | 243.93M |
Cash Flow | ||||||
| Free Cash Flow | -37.32M | -40.27M | -48.42M | -110.59M | -42.46M | -8.04M |
| Operating Cash Flow | -23.90M | -15.13M | -19.77M | -62.10M | 3.25M | 33.60M |
| Investing Cash Flow | -15.93M | -28.22M | -18.84M | -56.86M | -140.25M | -43.48M |
| Financing Cash Flow | 3.98M | 14.97M | -151.14M | 1.62M | 11.84M | 483.84M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $301.08M | 8.98 | 49.42% | ― | -0.32% | 557.28% | |
62 Neutral | $346.24M | -5.12 | -25.48% | ― | -24.30% | -181.62% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
61 Neutral | $629.99M | -13.15 | -26.69% | ― | 13.09% | 32.34% | |
59 Neutral | $338.00M | -10.77 | -20.20% | ― | -6.23% | 28.57% | |
51 Neutral | $764.34M | -21.27 | -10.54% | ― | 6.54% | -19.17% | |
46 Neutral | $47.78M | -0.14 | -605.44% | ― | -23.03% | -107.34% |
On November 7, 2025, LivePerson, Inc. appointed Nathan “Tripp” Lane as a Class II director, with his term expiring at the 2026 Annual Meeting of Stockholders. This appointment follows an Exchange Agreement with former holders of the company’s 0% Senior Convertible Notes due 2026. Mr. Lane, founder of Delancey Cove LLC and a former director at several companies, brings extensive experience from his previous roles in investment and advisory firms. His appointment is expected to enhance LivePerson’s governance and strategic direction.
The most recent analyst rating on (LPSN) stock is a Hold with a $8.00 price target. To see the full list of analyst forecasts on Liveperson stock, see the LPSN Stock Forecast page.
On October 14, 2025, LivePerson appointed Ryan L. Vardeman as a Class III director on its Board of Directors, with his term set to expire at the 2027 Annual Meeting of Stockholders. Vardeman, co-founder of Palogic Value Management, brings extensive experience in finance, corporate strategy, and investment management, particularly in technology and software sectors. His appointment follows an Exchange Agreement involving the company’s 2026 Notes. The company believes Vardeman’s expertise will support its strategic goals and enhance shareholder value.
The most recent analyst rating on (LPSN) stock is a Hold with a $1.00 price target. To see the full list of analyst forecasts on Liveperson stock, see the LPSN Stock Forecast page.
On October 2, 2025, LivePerson’s stockholders approved a reverse stock split at a ratio of 1-for-15, which was later ratified by the Board of Directors. This decision, effective October 13, 2025, aims to reduce the number of authorized common shares from 300 million to 20 million and adjust the company’s equity plans, warrants, and convertible notes accordingly. The reverse stock split is expected to impact the company’s trading on the Nasdaq Global Select Market, potentially aiding compliance with listing requirements and influencing the company’s market positioning.
The most recent analyst rating on (LPSN) stock is a Hold with a $1.00 price target. To see the full list of analyst forecasts on Liveperson stock, see the LPSN Stock Forecast page.
On October 2, 2025, LivePerson, Inc. held a special meeting where stockholders approved significant amendments to the company’s Certificate of Incorporation. The amendments included a reverse stock split of the Common Stock, with a ratio to be determined by the Board, and an increase in the number of authorized shares of Common Stock by 1.5 times. These changes led to the conversion of all Series B Preferred Stock into Common Stock, with the new shares expected to be issued on October 7, 2025.
The most recent analyst rating on (LPSN) stock is a Hold with a $1.00 price target. To see the full list of analyst forecasts on Liveperson stock, see the LPSN Stock Forecast page.